These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 28972438)

  • 1. Absence of association between Guillain-Barré syndrome hospitalizations and HPV-vaccine.
    Deceuninck G; Sauvageau C; Gilca V; Boulianne N; De Serres G
    Expert Rev Vaccines; 2018 Jan; 17(1):99-102. PubMed ID: 28972438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus vaccination and risk of autoimmune diseases: A large cohort study of over 2million young girls in France.
    Miranda S; Chaignot C; Collin C; Dray-Spira R; Weill A; Zureik M
    Vaccine; 2017 Aug; 35(36):4761-4768. PubMed ID: 28750853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No increased risk of Guillain-Barré syndrome after human papilloma virus vaccine: A self-controlled case-series study in England.
    Andrews N; Stowe J; Miller E
    Vaccine; 2017 Mar; 35(13):1729-1732. PubMed ID: 28245941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of Guillain-Barré syndrome following H1N1 influenza vaccination in Quebec.
    De Wals P; Deceuninck G; Toth E; Boulianne N; Brunet D; Boucher RM; Landry M; De Serres G
    JAMA; 2012 Jul; 308(2):175-81. PubMed ID: 22782419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between Guillain-Barré syndrome, influenza-related hospitalizations, and influenza vaccine coverage.
    Iqbal S; Li R; Gargiullo P; Vellozzi C
    Vaccine; 2015 Apr; 33(17):2045-9. PubMed ID: 25749247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Papillomavirus vaccination and Guillain-Barre Syndrome among girls: A cohort study in Spain.
    Martín-Merino E; Castillo-Cano B; Martín-Perez M; Llorente-García A; Montero-Corominas D
    Vaccine; 2021 Jul; 39(31):4306-4313. PubMed ID: 34175126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines.
    Dodd CN; Romio SA; Black S; Vellozzi C; Andrews N; Sturkenboom M; Zuber P; Hua W; Bonhoeffer J; Buttery J; Crawford N; Deceuninck G; de Vries C; De Wals P; Gutierrez-Gimeno MV; Heijbel H; Hughes H; Hur K; Hviid A; Kelman J; Kilpi T; Chuang SK; Macartney K; Rett M; Lopez-Callada VR; Salmon D; Gimenez-Sanchez F; Sanz N; Silverman B; Storsaeter J; Thirugnanam U; van der Maas N; Yih K; Zhang T; Izurieta H;
    Vaccine; 2013 Sep; 31(40):4448-58. PubMed ID: 23770307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guillain-Barre syndrome following quadrivalent human papillomavirus vaccination among vaccine-eligible individuals in the United States.
    Ojha RP; Jackson BE; Tota JE; Offutt-Powell TN; Singh KP; Bae S
    Hum Vaccin Immunother; 2014; 10(1):232-7. PubMed ID: 24013368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of Guillain-Barré syndrome after exposure to pandemic influenza A(H1N1)pdm09 vaccination or infection: a Norwegian population-based cohort study.
    Ghaderi S; Gunnes N; Bakken IJ; Magnus P; Trogstad L; Håberg SE
    Eur J Epidemiol; 2016 Jan; 31(1):67-72. PubMed ID: 26008750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of mid-and long-term benefits and hypothetical risk of Guillain-Barre syndrome after human papillomavirus vaccination among boys in France: A simulation study.
    Duong CH; Mueller JE; Tubert-Bitter P; Escolano S
    Vaccine; 2022 Jan; 40(2):359-363. PubMed ID: 34865876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus vaccines and Guillain-Barré syndrome: managing uncertainties.
    Prescrire Int; 2016 Nov; 25(176):265-268. PubMed ID: 30715823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of Guillain-Barré syndrome after seasonal influenza vaccination and influenza health-care encounters: a self-controlled study.
    Kwong JC; Vasa PP; Campitelli MA; Hawken S; Wilson K; Rosella LC; Stukel TA; Crowcroft NS; McGeer AJ; Zinman L; Deeks SL
    Lancet Infect Dis; 2013 Sep; 13(9):769-76. PubMed ID: 23810252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guillain-Barré syndrome after influenza vaccination in adults: a population-based study.
    Juurlink DN; Stukel TA; Kwong J; Kopp A; McGeer A; Upshur RE; Manuel DG; Moineddin R; Wilson K
    Arch Intern Med; 2006 Nov; 166(20):2217-21. PubMed ID: 17101939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of Guillain-Barré Syndrome following quadrivalent human papillomavirus vaccine in the Vaccine Safety Datalink.
    Gee J; Sukumaran L; Weintraub E;
    Vaccine; 2017 Oct; 35(43):5756-5758. PubMed ID: 28935469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between occurrence of Guillain-Barre syndrome and mass campaign of measles and rubella immunization in Iranian 5-14 years old children.
    Esteghamati A; Gouya MM; Keshtkar AA; Mahoney F
    Vaccine; 2008 Sep; 26(39):5058-61. PubMed ID: 18662736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guillain-Barré syndrome after Gardasil vaccination: data from Vaccine Adverse Event Reporting System 2006-2009.
    Souayah N; Michas-Martin PA; Nasar A; Krivitskaya N; Yacoub HA; Khan H; Qureshi AI
    Vaccine; 2011 Jan; 29(5):886-9. PubMed ID: 20869467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus vaccine uptake in boys and girls in a school-based vaccine delivery program in Prince Edward Island, Canada.
    McClure CA; MacSwain MA; Morrison H; Sanford CJ
    Vaccine; 2015 Apr; 33(15):1786-90. PubMed ID: 25731789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPV vaccination and risk of chronic fatigue syndrome/myalgic encephalomyelitis: A nationwide register-based study from Norway.
    Feiring B; Laake I; Bakken IJ; Greve-Isdahl M; Wyller VB; Håberg SE; Magnus P; Trogstad L
    Vaccine; 2017 Jul; 35(33):4203-4212. PubMed ID: 28648542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of the risk of autoimmune thyroiditis, Guillain-Barré syndrome, and inflammatory bowel disease following vaccination with AS04-adjuvanted human papillomavirus 16/18 vaccine.
    Rosillon D; Willame C; Tavares Da Silva F; Guignard A; Caterina S; Welby S; Struyf F
    Pharmacoepidemiol Drug Saf; 2020 Sep; 29(9):1159-1167. PubMed ID: 32583515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Jun; 59(21):657-61. PubMed ID: 20520590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.